The role of microglia in the pathobiology of neuropathic pain development: What do we know?

British Journal of Anaesthesia

Volumn 118, Issue 4, 2017, Pages 504-516

  Zhao, H ^a   Alam, A ^a   Chen, Q ^a,b   Eusman, M A ^a   Pal, A ^a   Eguchi, S ^a   Wu, L ^a   Ma, D ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

astrocytes; cytokines; microglia; neuropathic pain

Indexed keywords

CYTOKINE; FRACTALKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEU DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR;

ALLODYNIA; ANXIETY; ARTICLE; ASTROCYTE; COMORBIDITY; DEPRESSION; EPITHELIUM CELL; GLIA; HUMAN; INTERNEURON; MAST CELL; MICROGLIA; NERVE CELL; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; OLIGODENDROGLIA; PATHOLOGY; PRIORITY JOURNAL; SLEEP DEPRIVATION; SOMATOSENSORY SYSTEM; T LYMPHOCYTE; ANIMAL; HYPERALGESIA; NEURALGIA;

ANIMALS; HUMANS; HYPERALGESIA; MICROGLIA; NEURALGIA;

EID: 85019246010     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aex006     Document Type: Review

References (112)

1. Jensen TS, Baron R, Haanpaa M, et al. A new definition of neuropathic pain. Pain 2011; 152: 2204-5
2. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: A maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009; 32: 1-32
3. Szczudlik A, Dobrogowski J, Wordliczek J, et al. Diagnosis and management of neuropathic pain: Review of literature and recommendations of the polish association for the study of pain and the polish neurological society-part two. Neurol Neurochir Pol 2014; 48: 423-35
4. Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010; 229: 26-50
5. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol 2015; 14: 162-73
6. Cohen SP, Mao J. Neuropathic pain: Mechanisms and their clinical implications. Br Med J 2014; 348: F7656
7. Calvo M, Bennett DL. The mechanisms of microgliosis and pain following peripheral nerve injury. Exp Neurol 2012; 234: 271-82
8. von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012; 73: 638-52
9. Suter MR, Wen YR, Decosterd I, Ji RR. Do glial cells control pain. Neuron Glia Biol 2007; 3: 255-68
10. Echeverry S, Shi XQ, Zhang J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 2008; 135: 37-47
11. Decosterd I, Woolf CJ. Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain 2000; 87: 149-58
12. Tsuda M, Shigemoto-Mogami Y, Koizumi S, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003; 424: 778-83
13. Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 2004; 20: 1150-60
14. Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 2007; 21: 642-51
15. Ji RR, Suter MR. p38 MAPK, microglial signalling, neuropathic pain. Mol Pain 2007; 3: 33
16. Ji RR, Gereau RWt, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009; 60: 135-48
17. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003; 23: 4017-22
18. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004; 45: 89-95
19. Clark AK, Gentry C, Bradbury EJ, McMahon SB, Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur J Pain 2007; 11: 223-30
20. Xiang Y, Liu T, Yang H, et al. NRG1-ErbB signalling promotes microglia activation contributing to incision-induced mechanical allodynia. Eur J Pain 2015; 19: 686-94
21. Calvo M, Zhu N, Grist J, Ma Z, Loeb JA, Bennett DL. Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia 2011; 59: 554-68
22. Kawasaki Y, Xu ZZ, Wang X, et al. Distinct roles of matrix metalloproteases in the early-A nd late-phase development of neuropathic pain. Nat Med 2008; 14: 331-6
23. Liou JT, Sum DC, Liu FC, Mao CC, Lai YS, Day YJ. Spatial and temporal analysis of nociception-related spinal cord matrix metalloproteinase expression in a murine neuropathic pain model. J Chin Med Assoc 2013; 76: 201-10
24. Rojewska E, Popiolek-Barczyk K, Jurga AM, Makuch W, Przewlocka B, Mika J. Involvement of pro-A nd antinociceptive factors in minocycline analgesia in rat neuropathic pain model. J Neuroimmunol 2014; 277: 57-66
25. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. Importance of glial activation in neuropathic pain. Eur J Pharmacol 2013; 716: 106-19
26. White FA, Sun J, Waters SM, et al. Excitatory monocyte chemoattractant protein-1 signalling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA 2005; 102: 14092-7
27. Thacker MA, Clark AK, Bishop T, et al. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 2009; 13: 263-72
28. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S. Expression of CCR2 in both resident and bone marrowderived microglia plays a critical role in neuropathic pain. J Neurosci 2007; 27: 12396-406
29. Dansereau MA, Gosselin RD, Pohl M, et al. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 2008; 106: 757-69
30. Clark AK, Wodarski R, Guida F, Sasso O, Malcangio M. Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor. Glia 2010; 58: 1710-26
31. Sun JL, Xiao C, Lu B, et al. CX3CL1/CX3CR1 regulates nerve injury-induced pain hypersensitivity through the ERK5 signalling pathway. J Neurosci Res 2013; 91: 545-53
32. Calvo M, Zhu N, Tsantoulas C, et al. Neuregulin-ErbB signalling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci 2010; 30: 5437-50
33. Fu R, Shen Q, Xu P, Luo JJ, Tang Y. Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol 2014; 49: 1422-34
34. Nakajima K, Kohsaka S. Microglia: Activation and their significance in the central nervous system. J Biochem 2001; 130: 169-75
35. Mika J, Osikowicz M, Rojewska E, et al. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur J Pharmacol 2009; 623: 65-72
36. Obata H, Eisenach JC, Hussain H, Bynum T, Vincler M. Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. J Pain 2006; 7: 816-22
37. Tanga FY, Raghavendra V, DeLeo JA. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 2004; 45: 397-407
38. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1beta, interleukin-6, tumor necrosis factoralpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008; 28: 5189-94
39. Youn DH, Wang H, Jeong SJ. Exogenous tumor necrosis factor-alpha rapidly alters synaptic and sensory transmission in the adult rat spinal cord dorsal horn. J Neurosci Res 2008; 86: 2867-75
40. Zhang L, Berta T, Xu ZZ, Liu T, Park JY, Ji RR. TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: Distinct role of TNF receptor subtypes 1 and 2. Pain 2011; 152: 419-27
41. Clark AK, Old EA, Malcangio M. Neuropathic pain and cytokines: Current perspectives. J Pain Res 2013; 6: 803-14
42. Gabay E, Wolf G, Shavit Y, Yirmiya R, Tal M. Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. Eur J Pain 2011; 15: 242-8
43. Lee HL, Lee KM, Son SJ, Hwang SH, Cho HJ. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 2004; 15: 2807-11
44. Zanjani TM, Sabetkasaei M, Mosaffa N, Manaheji H, Labibi F, Farokhi B. Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol 2006; 538: 66-72
45. Latremoliere A, Mauborgne A, Masson J, et al. Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats. J Neurosci 2008; 28: 8489-501
46. Mei XP, Chen L, Wang W and co-workers. Combination of tramadol with minocycline exerted synergistic effects on a rat model of nerve injury-induced neuropathic pain. Neurosignals 2013; 21: 184-96
47. Guasti L, Richardson D, Jhaveri M, et al. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol Pain 2009; 5: 35
48. Lin CS, Tsaur ML, Chen CC, et al. Chronic intrathecal infusion of minocycline prevents the development of spinalnerve ligation-induced pain in rats. Reg Anesth Pain Med 2007; 32: 209-16
49. Mika J. Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacol Rep 2008; 60: 297-307
50. Hutchinson MR, Northcutt AL, Chao LW, et al. Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, enhances systemic morphine-induced analgesia. Brain Behav Immun 2008; 22: 1248-56
51. Coull JA, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005; 438: 1017-21
52. Prescott SA, Sejnowski TJ, De Koninck Y. Reduction of anion reversal potential subverts the inhibitory control of firing rate in spinal lamina I neurons: Towards a biophysical basis for neuropathic pain. Mol Pain 2006; 2: 32
53. Lopez-Alvarez VM, Modol L, Navarro X, Cobianchi S. Early increasing-intensity treadmill exercise reduces neuropathic pain by preventing nociceptor collateral sprouting and disruption of chloride cotransporters homeostasis after peripheral nerve injury. Pain 2015; 156: 1812-25
54. Almeida C, DeMaman A, Kusuda R, et al. Exercise therapy normalizes BDNF upregulation and glial hyperactivity in a mouse model of neuropathic pain. Pain 2015; 156: 504-13
55. Kim YJ, Byun JH, Choi IS. Effect of exercise on micro-opioid receptor expression in the rostral ventromedial medulla in neuropathic pain rat model. Ann Rehabil Med 2015; 39: 331-9
56. Zychowska M, Rojewska E, Makuch W, Przewlocka B, Mika J. The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain. Eur J Pharmacol 2015; 749: 115-23
57. David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 2011; 12: 388-99
58. Crain JM, Nikodemova M, Watters JJ. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res 2013; 91: 1143-51
59. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-44
60. Popiolek-Barczyk K, Kolosowska N, Piotrowska A, et al. Parthenolide relieves pain and promotes M2 microglia/macrophage polarization in rat model of neuropathy. Neural Plast 2015; 2015: 676473
61. Magni P, Ruscica M, Dozio E, Rizzi E, Beretta G, Maffei Facino R. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-alpha and NF-kappaB nuclear translocation in BV-2 microglia. Phytother Res 2012; 26: 1405-9
62. Nazemi S, Manaheji H, Noorbakhsh SM, et al. Inhibition of microglial activity alters spinal wide dynamic range neuron discharge and reduces microglial Toll-like receptor 4 expression in neuropathic rats. Clin Exp Pharmacol Physiol 2015; 42: 772-9
63. Yamamoto Y, Terayama R, Kishimoto N, et al. Activated microglia contribute to convergent nociceptive inputs to spinal dorsal horn neurons and the development of neuropathic pain. Neurochem Res 2015; 40: 1000-12
64. Bian C, Wang ZC, Yang JL, Lu N, Zhao ZQ, Zhang YQ. Upregulation of interleukin-23 induces persistent allodynia via CX3CL1 and interleukin-18 signalling in the rat spinal cord after tetanic sciatic stimulation. Brain Behav Immun 2014; 37: 220-30
65. Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci 2008; 28: 12775-87
66. Tanuma N, Sakuma H, Sasaki A, Matsumoto Y. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol 2006; 112: 195-204
67. Batlle M, Ferri L, Andrade C, et al. Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus. Biomed Res Int 2015; 2015: 102419
68. Van Eldik LJ, Wainwright MS. The janus face of glial-derived S100B: Beneficial and detrimental functions in the brain. Restor Neurol Neurosci 2003; 21: 97-108
69. Reali C, Scintu F, Pillai R, Donato R, Michetti F, Sogos V. S100b counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia. J Neurosci Res 2005; 81: 677-86
70. Yang Y, Li H, Li TT, et al. Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18. J Neurosci 2015; 35: 7950-63
71. Ji XT, Qian NS, Zhang T, et al. Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapyinduced neuropathic pain model. PLoS One 2013; 8: E60733
72. Di Cesare Mannelli L, Pacini A, Micheli L, Tani A, Zanardelli M, Ghelardini C. Glial role in oxaliplatin-induced neuropathic pain. Exp Neurol 2014; 261: 22-33
73. DosSantos MF, Holanda-Afonso RC, Lima RL, DaSilva AF, Moura-Neto V. The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci 2014; 8: 302
74. Huber JD, Witt KA, Hom S, Egleton RD, Mark KS, Davis TP. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol 2001; 280: H1241-8
75. Campos CR, Ocheltree SM, Hom S, Egleton RD, Davis TP. Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Res 2008; 1221: 6-13
76. Kim M, Carman CV, Springer TA. Bidirectional transmembrane signalling by cytoplasmic domain separation in integrins. Science 2003; 301: 1720-5
77. Zameer A, Hoffman SA. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J Neuroimmunol 2003; 142: 67-74
78. Kyrkanides S, Moore AH, Olschowka JA, et al. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res Mol Brain Res 2002; 104: 159-69
79. Kyrkanides S, O'banion MK, Whiteley PE, Daeschner JC, Olschowka JA. Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury. J Neuroimmunol 2001; 119: 269-77
80. Huber JD, Campos CR, Mark KS, Davis TP. Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. Am J Physiol Heart Circ Physiol 2006; 290: H732-40
81. Gritsch S, Lu J, Thilemann S, et al. Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice. Nat Commun 2014; 5: 5472
82. Zarpelon AC, Rodrigues FC, Lopes AH, et al. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB J 2016 Jan; 30: 54-65
83. Xanthos DN, Gaderer S, Drdla R, et al. Central nervous system mast cells in peripheral inflammatory nociception. Mol Pain 2011; 7: 42
84. Zuo Y, Perkins NM, Tracey DJ, Geczy CL. Inflammation and hyperalgesia induced by nerve injury in the rat: A key role of mast cells. Pain 2003; 105: 467-79
85. Levy D, Kainz V, Burstein R, Strassman AM. Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity. Brain Behav Immun 2012; 26: 311-7
86. Silverman AJ, Sutherland AK, Wilhelm M, Silver R. Mast cells migrate from blood to brain. J Neurosci 2000; 20: 401-8
87. Skaper SD, Facci L, Giusti P. Mast cells, glia and neuroinflammation: Partners in crime. Immunology 2014; 141: 314-27
88. Zhang S, Zeng X, Yang H, Hu G, He S. Mast cell tryptase induces microglia activation via protease-activated receptor 2 signalling. Cell Physiol Biochem 2012; 29: 931-40
89. Trang T, Beggs S, Wan X, Salter MW. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 2009; 29: 3518-28
90. Cao L, DeLeo JA. CNS-infiltrating CD4\+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol 2008; 38: 448-58
91. Costigan M, Moss A, Latremoliere A, et al. T-cell infiltration and signalling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci 2009; 29: 14415-22
92. Moalem G, Xu K, Yu L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience 2004; 129: 767-77
93. Zhang X, Wu Z, Hayashi Y, Okada R, Nakanishi H. Peripheral role of cathepsin S in Th1 cell-dependent transition of nerve injury-induced acute pain to a chronic pain state. J Neurosci 2014; 34: 3013-22
94. Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K. IFN-gamma receptor signalling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci USA 2009; 106: 8032-7
95. Matyszak MK, Denis-Donini S, Citterio S, Longhi R, Granucci F, Ricciardi-Castagnoli P. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. Eur J Immunol 1999; 29: 3063-76
96. Togo T, Akiyama H, Kondo H, et al. Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases. Brain Res 2000; 885: 117-21
97. D'aversa TG, Weidenheim KM, Berman JW. CD40-CD40L interactions induce chemokine expression by human microglia: Implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am J Pathol 2002; 160: 559-67
98. Cao L, Palmer CD, Malon JT, De Leo JA. Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain. Eur J Immunol 2009; 39: 3562-9
99. Garrido-Mesa N, Zarzuelo A, Galvez J. Minocycline: Far beyond an antibiotic. Br J Pharmacol 2013; 169: 337-52
100. Mei XP, Xu H, Xie C, et al. Post-injury administration of minocycline: An effective treatment for nerve-injury induced neuropathic pain. Neurosci Res 2011; 70: 305-12
101. Kunori S, Matsumura S, Okuda-Ashitaka E, et al. A novel role of prostaglandin E2 in neuropathic pain: Blockade of microglial migration in the spinal cord. Glia 2011; 59: 208-18
102. Eisenach JC, Curry R, Rauck R, Pan P, Yaksh TL. Role of spinal cyclooxygenase in human postoperative and chronic pain. Anesthesiology 2010; 112: 1225-33
103. Willemen HL, Huo XJ, Mao-Ying QL, Zijlstra J, Heijnen CJ, Kavelaars A. MicroRNA-124 as a novel treatment for persistent hyperalgesia. J Neuroinflammation 2012; 9: 143
104. Savage S, Ma D. Experimental behaviour testing: Pain. Br J Anaesth 2015; 114: 721-4
105. Wallace VC, Blackbeard J, Pheby T, et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007; 133: 47-63
106. Chung JM, Kim HK, Chung K. Segmental spinal nerve ligation model of neuropathic pain. Methods Mol Med 2004; 99: 35-45
107. Austin PJ, Wu A, Moalem-Taylor G. Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats. J Vis Exp 2012
108. Lambert GA, Mallos G, Zagami AS. Von Frey's hairs-a review of their technology and use-a novel automated von Frey device for improved testing for hyperalgesia. J Neurosci Methods 2009; 177: 420-6
109. Detloff MR, Clark LM, Hutchinson KJ, Kloos AD, Fisher LC, Basso DM. Validity of acute and chronic tactile sensory testing after spinal cord injury in rats. Exp Neurol 2010; 225: 366-76
110. Hogan Q, Sapunar D, Modric-Jednacak K, McCallum JB. Detection of neuropathic pain in a rat model of peripheral nerve injury. Anesthesiology 2004; 101: 476-87
111. Anseloni VC, Ennis M, Lidow MS. Optimization of the mechanical nociceptive threshold testing with the Randall-Selitto assay. J Neurosci Methods 2003; 131: 93-7
112. Lee EB, Li DW, Hyun JE, Kim IH, Whang WK. Anti-inflammatory activity of methanol extract of Kalopanax pictus bark and its fractions. J Ethnopharmacol 2001; 77: 197-201